Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

NCT06165900 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Stereotactic Radiotherapy
Immunotherapy
Breast Cancer

Interventions

DRUG: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)
DRUG: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)

Sponsor

Shengjing Hospital